Primer: PrimeGenX Therapeutics (PGX HK) - Aug 2026
PrimeGenX Therapeutics is a clinical-stage biotechnology company with a focused pipeline on locally-delivered targeted therapies for...
PrimeGenX Therapeutics (PGX HK): Synthetic Expert Call Transcript (26 Jul 2026)
Pumecitinib (PG-011) Gel's competitive edge in China's crowded atopic dermatitis market relies heavily on its unique gel formulation over standard...
IPO Databook: PrimeGenX Therapeutics (HK) - Jul 2026
PrimeGenX Therapeutics Co., Ltd. is a biotech company founded in 2016, specializing in locally-delivered targeted therapies for...
No more insights